临床试验/NCT01579955

NCT01579955已完成不适用

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

Novo Nordisk A/S1 个研究点分布在 1 个国家目标入组 321 人开始时间: 1999年3月10日最近更新: 2017年2月24日

适应症

干预措施

试验速览

阶段: 不适用
状态: 已完成
发起方: Novo Nordisk A/S
入组人数: 321
试验地点: 1
主要终点: Percentage of bleed treatments resulting in effective bleed resolution: Markedly effective, effective, moderate or ineffective

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This study is conducted in Japan. The aim of this non-interventional study is to investigate the safety and effectiveness of treatment with eptacog alpha (NovoSeven®) under normal clinical practice conditions.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

性别: All
接受健康志愿者: 否

入选标准

•Patients with haemophilia A and B with inhibitors who received eptacog alpha (NovoSeven®) as treatment

排除标准

•Patients who was not deemed to be appropriate to the treatment of eptacog alpha (NovoSeven®)

研究组 & 干预措施

eptacog alpha users

干预措施: eptacog alfa (activated) (Drug)

结局指标

主要结局

Percentage of bleed treatments resulting in effective bleed resolution: Markedly effective, effective, moderate or ineffective

时间窗: Year 10

次要结局

Number of adverse events (AEs), including serious adverse events (SAEs)(Baseline, every 1 year, Year 10)

研究者

发起方

Novo Nordisk A/S

申办方类型

Industry

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

已完成

不适用

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing SurgeryCongenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors

NCT01579968Novo Nordisk A/S86

已完成

不适用

A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in JapanCongenital Bleeding DisorderGlanzmann's Disease

NCT01876745Novo Nordisk A/S4

已完成

不适用

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in GermanyCongenital Bleeding DisorderCongenital FVII DeficiencyGlanzmann's DiseaseAcquired Bleeding DisorderAcquired Haemophilia

NCT00697320Novo Nordisk A/S64

已完成

2 期

Use of NovoSeven® in Active Variceal BleedingAcquired Bleeding DisorderCirrhosis

NCT00154492Novo Nordisk A/S265

已完成

不适用

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner SyndromeGrowth Hormone Deficiency in ChildrenGrowth Hormone DisorderGenetic DisorderTurner Syndrome

NCT01604161Novo Nordisk A/S2,016